K2 Principal Fund’s Urovant Sciences Ltd. UROV Stock Holding History

K2 Principal Fund’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-146,556	Closed	-$2.36M	–	476
2020 Q4	$2.36M	Buy	+146,556	New	+$1.82M	0.21%	140

K2 Principal Fund's UROV Position: Q1 2021 in Review

K2 Principal Fund sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 146,556 shares — an estimated $2.36M sold.

K2 Principal Fund first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $2.36M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

K2 Principal Fund reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
K2 Principal Fund sold 146,556 Urovant Sciences Ltd. shares in Q1 2021, an estimated $2.36M.
K2 Principal Fund first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
K2 Principal Fund's Urovant Sciences Ltd. position peaked at $2.36M in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on K2 Principal Fund's 13F filing for Q1 2021, filed 14 May 2021.